【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Highlights
PART 05: Global pharmaceutical market
• Market size and forecast
PART 06: Road to pharmerging markets
PART 07: Pharmerging markets
PART 08: Market landscape
• Medicine spending in emerging economies
• Five forces analysis
PART 09: Market segmentation by geography
PART 10: Market overview of tier I countries
• China
PART 11: Market overview of tier II countries
• Brazil
• Russia
• India
PART 12: Market overview of tier III countries
• Market size and forecast
PART 13: Market drivers
• Limitations in developed economies fuels demand in emerging economies
• Increasing focus toward biosimilar in potential areas
• Expansion initiatives of vendors
PART 14: Impact of drivers
PART 15: Market challenges
• IP protection issues
• Socio-political issues in cross geography transactions
• Stringent price control and generic-centric usage lead to value erosion
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Potential of new countries in emerging markets
• Positive outlook toward adoption of targeted therapies
• Evolving stakeholder landscape to change market dynamics
PART 18: Vendor landscape
• Competitive scenario
PART 19: Key vendor analysis
• AstraZeneca
• GlaxoSmithKline
• Pfizer
• Sanofi
• Novartis
• Other prominent vendors
PART 20: Appendix
• List of Abbreviations
PART 21: Explore Technavio
[List of Exhibits]
Exhibit 01: Global country rankings in pharmaceutical market based on healthcare spending
Exhibit 02: Global pharmaceutical market 2016-2021 ($ trillions)
Exhibit 03: Drivers, challenges and trends of global pharmaceutical market
Exhibit 04: Growth comparision between developed markets and pharmerging markets
Exhibit 05: Share of pharmerging markets in global pharmaceutical market, 2016
Exhibit 06: Snapshot of key pharmerging markets
Exhibit 07: Regulatory landscape in key pharmerging markets
Exhibit 08: Pharmerging markets 2016-2021 ($ billions)
Exhibit 09: Comparison of medicine spending in developed economies and pharmerging markets
Exhibit 10: Medicine spending and growth rates in pharmerging markets
Exhibit 11: Standard units in 2021 by product type in pharmerging countries
Exhibit 12: Expected medicine spending by geography
Exhibit 13: Volume growth and population with more than $5,000/year income by country 2016
Exhibit 14: Percentage share of pharmerging markets in global pharmaceutical market 2016-2021
Exhibit 15: Percentage share of tier I, II and III countries in total pharmerging markets 2016-2021
Exhibit 16: Pharmerging markets share by country, 2016
Exhibit 17: Five forces analysis
Exhibit 18: Pharmerging markets segment by geography
Exhibit 19: Geographic representation of tier I country
Exhibit 20: China GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 21: On-going healthcare reforms in China
Exhibit 22: Segmentation of Chinese pharmaceutical market
Exhibit 23: Segment analysis in Chinese pharmaceutical market
Exhibit 24: Regulatory bodies
Exhibit 25: Major therapy areas based on sales of drugs, 2016
Exhibit 26: Major acquisitions in Chinese pharmaceutical market 2014-2016
Exhibit 27: Drivers and challenges in Chinese pharmaceutical market
Exhibit 28: Pharmaceutical market in China 2016-2021 ($ billions)
Exhibit 29: China pharmaceutical market: SWOT analysis
Exhibit 30: Geographic representation of tier II countries
Exhibit 31: Pharmaceutical market in tier II countries 2016-2021 ($ billions)
Exhibit 32: Brazil GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 33: Regulatory bodies
Exhibit 34: Segmentation of pharmaceutical market in Brazil 2016
Exhibit 35: Major acquisitions in Brazil pharmaceutical market
Exhibit 36: Drivers and challenges in Brazilian pharmaceutical market
Exhibit 37: Pharmaceutical market in Brazil 2016-2021 ($ billions)
Exhibit 38: Brazil pharmaceutical market: SWOT analysis
Exhibit 39: Russia GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 40: Major acquisitions in Russian pharmaceutical market
Exhibit 41: Drivers and challenges in Russian pharmaceutical market
Exhibit 42: Pharmaceutical market in Russia 2016-2021 ($ billions)
Exhibit 43: Russia pharmaceutical market: SWOT analysis
Exhibit 44: India GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 45: Regulatory landscape
Exhibit 46: Major acquisitions in pharmaceutical sector in India
Exhibit 47: Drivers and challenges in Indian pharmaceutical market
Exhibit 48: Pharmaceutical market in India 2016-2021 ($ billions)
Exhibit 49: India pharmaceutical market: SWOT analysis
Exhibit 50: Geographic representation of tier III countries
Exhibit 51: Pharmaceutical market in tier III countries 2016-2021 ($ billions)
Exhibit 52: Revenues from pharmaceuticals for few of the tier III countries 2016 ($ billions)
Exhibit 53: Snapshot of key countries in tier III countries
Exhibit 54: Tier III countries pharmaceutical market: SWOT analysis
Exhibit 55: Factors that are driving the growth in emerging economies
Exhibit 56: Biosimilar development in emerging economies
Exhibit 57: Few acquisitions and their impact
Exhibit 58: Impact of drivers
Exhibit 59: Impact of drivers and challenges
Exhibit 60: Positioning of key vendors in pharmerging markets 2015
Exhibit 61: Competitive analysis snapshot
Exhibit 62: Top selling products in emerging markets 2015
Exhibit 63: Key takeaways
Exhibit 64: Key highlights in emerging markets
Exhibit 65: AstraZeneca strength assessment
Exhibit 66: Geographic segmentation by revenue 2015
Exhibit 67: Key takeaways
Exhibit 68: Key highlights in emerging markets
Exhibit 69: GSK strength assessment
Exhibit 70: Geographic segmentation by revenue 2015
Exhibit 71: Key takeaways
Exhibit 72: Pfizer: YoY and growth rate in emerging markets
Exhibit 73: Segmentation by revenue in emerging markets ($ millions)
Exhibit 74: Key highlights in emerging markets
Exhibit 75: Pfizer strength assessment
Exhibit 76: Pfizer: Geographical segmentation by revenue 2015
Exhibit 77: Top selling products0
Exhibit 78: Key emerging products0
Exhibit 79: Geographical segmentation by revenue1
Exhibit 80: Key takeaways2
Exhibit 81: Key highlights in emerging markets2
Exhibit 82: Sanofi strength assessment3
Exhibit 83: Key takeaways4
Exhibit 84: Key highlights in emerging markets5
Exhibit 85: Novartis strength assessment6
Exhibit 86: Novartis: Geographical segmentation by revenue 20156
【レポート販売概要】
■ タイトル：医薬品新興国市場2017-2021■ 英文：Global Pharmerging Markets 2017-2021
■ 発行日：2017年1月16日
■ 調査会社：Technavio
■ 商品コード：IRTNTR11577
■ 調査対象地域：ブラジル、ロシア、中国、インド、トルコ、メキシコ、韓国
- グローバル・エグゼクティブ・サーベイ：プライベート・ラベル市場における顧客の期待と企業の戦略的アプローチSummary “Private Label - Consumer Expectations and Organizations Strategic Approach” is a report published by Canadean with a detailed analysis about the quality of private label goods, organizations plans on adoption and strengthening of private label, also coverage of their apprehensions about private label brands and retailers. Key Findings - Overall, 61% of executives indicate that private lab …
- 2014年戦略提言：ドイツの止血診断検査市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.SummaryThis comprehensive report contains 406 pages, 38 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years. The report explores business and technol …
- ビデオウォールの世界市場：狭額縁ディスプレイ、背面投影ディスプレイAbout Video Walls Video walls are visual displays made up of multiple monitors or projectors that are tiled to form a single and large display screen. Such screens enable better engagement between the viewers and the digital content displayed on these devices. Video walls offer a large number of advantages to the users. Most important of all, it displays a much larger and higher-resolution image t …
- 世界のプロパント市場予測：非在来型石油・ガスの水圧破砕用フラクサンド・樹脂コート・セラミックプロパントContinual expansion of unconventional oil and gas development seen over the next decade – most notably in the US, but also around the globe – will necessitate steadily increasing proppant sales throughout the next ten years. In the US, proppant sales are primarily driven by the shale (tight) oil industry, since the natural gas price has decoupled from the crude oil price, making it more economical …
- 世界の軍事衛星市場：地域別分析Summary This report offers detailed analysis of the global Military Satellites market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Military Satellites market. Key Findings "The Global Military Satellites Market 2015-2025 - Country Analysis: Market Profile" provides details of the key market …
- 放電加工機（EDM）の世界市場2017-2021ABSTRACTAbout Electrical Discharge Machine Electrical discharge machines (EDMs) are used in the manufacturing process to obtain a desired shape by removing material from a workpiece. During this process, a rapidly recurring current is discharged between two electrodes, which cuts the material into the desired shape and the residual material is separated by a dielectric liquid. Technavio’s analysts …
- CNS疾患用遺伝子治療の世界市場2019-2023About this market The increase in special drug designations is one of the key factors anticipated to witness continuous growth in the forthcoming years. Vendors are receiving special drug designations for their novel gene therapies to help in receiving quicker approval. Some market players are even offering the orphan drug designation with various tax benefits on their clinical researches. As a re …
- ペストコントロールサービスの世界市場2019-2023About this market The increase in demand for insurance-based pest control services will drive the pest control services market growth during the forecast period. Significant costs associated with pest control services are propelling many vendors in the market to create insurance-based pest control services for both residential and commercial customers. Furthermore, the growing interest from custom …
- フレキシブルパイプの世界市場：HDPEパイプ、PAパイプ、PVDFパイプThe global flexible pipe market size is estimated to reach USD 1.02 Billion by 2020, at a CAGR of 3.7% between 2015 and 2020. The flexible pipes market is growing due to increasing offshore and onshore drilling and exploration processes. However, low oil prices are expected to inhibit the growth of the market to some extent. Flexible pipes are used for the transfer of fluids and liquids such as cr …
- 世界のビデオ監視ストレージ市場：製品別（SAN、NAS、DAS、ビデオレコーダー）、ストレージメディア別、エンタープライズサイズ別、用途別（商業、都市監視、産業）、展開モード別、業種別（教育、BFSI）、地域別The global Video Surveillance Storage (VSS) market size to grow at a Compound Annual Growth Rate (CAGR) of 18.1% during the forecast period. MarketsandMarkets forecasts the global VSS market size to grow from USD 7.6 billion in 2019 to USD 17.5 billion by 2024, at a CAGR of 18.1% during 2019–2024. Major growth factors for the market include the adoption of IP cameras and demand for video surveilla …
- ぶどう膜黒色腫(Uveal Melanoma)：治療薬開発パイプライン動向（2015年上半期版）Uveal Melanoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H1 2015’, provides an overview of the Uveal Melanoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uveal Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ( …
- 脂肪性肝疾患(Fatty Liver Disease)：治療薬開発パイプライン動向（2015年上半期版）Fatty Liver Disease - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Fatty Liver Disease - Pipeline Review, H1 2015’, provides an overview of the Fatty Liver Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fatty Liver Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
- iPad in Healthcare: Challenges & OpportunitiesThe healthcare industry in the United States has been the sole industry keeping the moribund tablet computer market alive for several years. Although previous tablet-based computing devices have not enjoyed substantial consumer use computer-makers had thought they would, the healthcare industry's appetite for non-laptop portable computers can be traced back to the late 1990s, when technologists cr …
- 世界のエボラ診断、治療薬、ワクチン市場The Ebola Report - new study showing you trends and R&D progress What opportunities are there in a market for Ebola diagnostics, prevention, and treatment? What are the commercial prospects for this market and related technologies? Visiongain’s new report shows market potential for products and other trends, discussing data, opportunities and prospects. Our new 115 page report provides 40 tables, …
- 硬質プラスチック包装の世界市場2016-2026Visiongain’s new 282 page report assesses that the global rigid plastic packaging market will reach $188.45 billion in 2016. Are you involved in the Rigid Plastic Packaging market or intend to be? If so, then you must read this report It’s vital that you keep your industry knowledge up to date. You need this report. Market scope: This brand new report from visiongain is a completely fresh market a …
